| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11228275 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 471 journal articles in the PubMed database | Email to a friend | | |
| Turpie AG, Gallus AS, Hoek JA
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2001 Mar 1; 344(9):619-25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Turpie AG
Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice. [Clinical Trial, Journal Article, Randomized Controlled Trial, Review]
Am Heart J 2001 Aug; 142(2 Suppl):S9-15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Bauer KA, Lassen MR, et al.
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2001 Nov 1; 345(18):1298-304.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fitzgerald RH, Spiro TE, Trowbridge AA, et al.
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Bone Joint Surg Am 2001 Jun; 83-A(6):900-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bergqvist D, Benoni G, Björgell O, et al.
Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. [Clinical Trial, Journal Article, Randomized Controlled Trial]
N Engl J Med 1996 Sep 5; 335(10):696-700.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Colwell CW, Collis DK, Paulson R, et al.
Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Bone Joint Surg Am 1999 Jul; 81(7):932-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bauer KA, Eriksson BI, Lassen MR, et al.
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2001 Nov 1; 345(18):1305-10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Borris L, Dahl OE, et al.
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. [Journal Article, Multicenter Study, Randomized Controlled Trial]
J Thromb Haemost 2006 Jan; 4(1):121-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Agnelli G, Cohen AT, et al.
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Thromb Haemost 2003 Feb; 89(2):288-96.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
